MARKETING AUTHORISATION HOLDER

MARKETING AUTHORISATION HOLDER

Sanofi-Aventis Australia pty ltd.
12-24 Talavera Road Macquarie Park NSW 2113 Australia.

For further medical information, please contact the following:
Toll-Free Number for UAE:

800 4 Medical.

For all Gulf Countries:
CHCMedical-Information.Gulf@sanofi.com.

FULL PRESCRIBING INFORMATION

FULL PRESCRIBING INFORMATION

FULL PRESCRIBING INFORMATION ARE AVAILABLE UPON REQUEST AT:

Sanofi Regional Office, One JLT Building Level 3, Jumeirah Lake Towers, PO Box 53899, Dubai, UAE.
To report adverse events, please call: +971561747001
Or email: gulf.pharmacovigilance@sanofi.com.

Personal health questions must be discussed with healthcare professionals.
You should consult a physician or pharmacist before using a medicinal product. With best wishes from Ministry of Health and Prevention.

Telfast 120mg

Active ingredient: Fexofenadine hydrochloride 120 mg. Indication: Relieve the symptoms of hay fever (seasonal allergic rhinitis) such as sneezing, itchy, watery or red eyes and itchy, blocked or runny nose in adults and children aged 12 years or older. Dosage: This medicine is for adults and children over 12 years of age only. The dosage is one tablet daily. Contra-indications: Do not take Telfast if you are pregnant, intend to become pregnant, or if you are breastfeeding, unless advised to do so by a Doctor or Pharmacist. Do not take Telfast if you have had an allergic reaction allergy to fexofenadine, terfenadine or any of the other ingredients in Telfast. These are listed at the end of this leaflet. Do not give Telfast to children under 12 years of age. Do not take Telfast after the expiry date (EXP.) printed on the pack or if the packaging is damaged or shows signs of tampering. Common Side Effects: All medicines can cause side effects. Sometimes they are serious, but most of the time they are not. You may need medical treatment if you get some of the side effects. Although most people will not experience any, some of the side effects that may occur with Telfast are: headache, tiredness, nausea, indigestion, dizziness, drowsiness.


Telfast 180mg

Active ingredient: Fexofenadine hydrochloride 180 mg. Indication: Relieve the symptoms of hay fever (seasonal allergic rhinitis) such as sneezing, itchy, watery or red eyes and itchy, blocked or runny nose as well as the symptoms of urticaria otherwise known as hives or itchy rash in adults and children aged 12 years or older. Dosage: This medicine is for adults and children over 12 years of age only. The dosage is one tablet daily. Contra-indications: Do not take Telfast if you are pregnant, intend to become pregnant, or if you are breastfeeding, unless advised to do so by a Doctor or Pharmacist. Do not take Telfast if you have had an allergic reaction allergy to fexofenadine, terfenadine or any of the other ingredients in Telfast. These are listed at the end of this leaflet. Do not give Telfast to children under 12 years of age. Do not take Telfast after the expiry date (EXP.) printed on the pack or if the packaging is damaged or shows signs of tampering. Common Side Effects: All medicines can cause side effects. Sometimes they are serious, but most of the time they are not. You may need medical treatment if you get some of the side effects. Although most people will not experience any, some of the side effects that may occur with Telfast are: headache, tiredness, nausea, indigestion, dizziness, drowsiness.


Telfast-D

Active Ingredients: 60mg fexofenadine HCl & 120mg pseudoephedrine HCl. Telfast D Indication: Indication: For the relief of the symptoms of seasonal &perennial AR (including hay fever) with sinus/nasal congestion. Symptoms include : Nasal & sinus congestion, Sneezing, Itchy, runny nose, Watery, itchy eyes & Itchy throat. Common side effects (usually mild and short-lived) : Headache, nausea, fatigue, dry mouth, anorexia, drowsiness, difficulty sleeping, nervousness, excitability, restlessness, dizziness, fear or anxiety, rapid hearth beat, tremor, hallucinations. Contra-indications: very high blood pressure, severe coronary artery disease, narrow angle glaucoma, urinary retention, a sensitivity to adrenergic events (symptoms include insomnia, dizziness, weakness, tremor, or irregular hear beat), or if you have taken monoamine oxidase inhibitors (medicines used to treat depression) in the last 14 days.


MARKETING AUTHORISATION HOLDER

MARKETING AUTHORISATION HOLDER

Telfast (Sanofi-aventis France, France).

For further medical information, please contact the following:
Toll-Free Number for UAE:

800 4 Medical.

For all Gulf Countries:
CHCMedical-Information.Gulf@sanofi.com.

FULL PRESCRIBING INFORMATION

FULL PRESCRIBING INFORMATION

FULL PRESCRIBING INFORMATION ARE AVAILABLE UPON REQUEST AT:

Sanofi Regional Office, Jumeirah Lakes Towers, Dubai, UAE.
To report adverse events, please call: +971561747001
Or email: gulf.pharmacovigilance@sanofi.com.

Personal health questions must be discussed with healthcare professionals.
You should consult a physician or pharmacist before using a medicinal product. With best wishes from Ministry of Health and Prevention.